-
2
-
-
0033577725
-
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936
-
Sum PE, Petersen P (1999) Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936. Bioorg Med Chem Lett 9: 1459-1462.
-
(1999)
Bioorg Med Chem Lett
, vol.9
, pp. 1459-1462
-
-
Sum, P.E.1
Petersen, P.2
-
3
-
-
0032918653
-
In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936)
-
Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT (1999) In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother 43: 738-744. (Pubitemid 29165733)
-
(1999)
Antimicrobial Agents and Chemotherapy
, vol.43
, Issue.4
, pp. 738-744
-
-
Petersen, P.J.1
Jacobus, N.V.2
Weiss, W.J.3
Sum, P.E.4
Testa, R.T.5
-
4
-
-
34547464547
-
-
Wyeth Pharmaceuticals Inc. Available online: (Accessed 8 July 2013)
-
Wyeth Pharmaceuticals Inc. 2012) Tygacil: Full Prescribing Information. Available online: http://labeling.pfizer.com/showlabeling.aspx?id=491 (Accessed 8 July 2013).
-
(2012)
Tygacil: Full Prescribing Information
-
-
-
5
-
-
80054762740
-
Pharmacokinetic and pharmacodynamic evaluation of tigecycline
-
Giamarellou H, Poulakou G (2011) Pharmacokinetic and pharmacodynamic evaluation of tigecycline. Expert Opin Drug Metab Toxicol 7: 1459-1470.
-
(2011)
Expert Opin Drug Metab Toxicol
, vol.7
, pp. 1459-1470
-
-
Giamarellou, H.1
Poulakou, G.2
-
6
-
-
81255192118
-
Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia
-
Skrtic M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, et al. (2011) Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell 20: 674-688.
-
(2011)
Cancer Cell
, vol.20
, pp. 674-688
-
-
Skrtic, M.1
Sriskanthadevan, S.2
Jhas, B.3
Gebbia, M.4
Wang, X.5
-
7
-
-
3042810717
-
2+ cleavage of 16S rRNA
-
DOI 10.1093/jac/dkh125
-
Bauer G, Berens C, Projan SJ, Hillen W (2004) Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2 + cleavage of 16S rRNA. J Antimicrob Chemother 53: 592-599. (Pubitemid 38499772)
-
(2004)
Journal of Antimicrobial Chemotherapy
, vol.53
, Issue.4
, pp. 592-599
-
-
Bauer, G.1
Berens, C.2
Projan, S.J.3
Hillen, W.4
-
8
-
-
33744458965
-
Functional, biophysical, and structural bases for antibacterial activity of tigecycline
-
DOI 10.1128/AAC.01499-05
-
Olson MW, Ruzin A, Feyfant E, Rush TS, 3rd, O'Connell J, et al. (2006) Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother 50: 2156-2166. (Pubitemid 43807538)
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, Issue.6
, pp. 2156-2166
-
-
Olson, M.W.1
Ruzin, A.2
Feyfant, E.3
Rush III, T.S.4
O'Connell, J.5
Bradford, P.A.6
-
9
-
-
84874605802
-
Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis
-
Jenner L, Starosta AL, Terry DS, Mikolajka A, Filonava L, et al. (2013) Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc Natl Acad Sci U S A 110: 3812-3816.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. 3812-3816
-
-
Jenner, L.1
Starosta, A.L.2
Terry, D.S.3
Mikolajka, A.4
Filonava, L.5
-
11
-
-
84875143073
-
BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells
-
Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, et al. (2013) BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12: 329-341.
-
(2013)
Cell Stem Cell
, vol.12
, pp. 329-341
-
-
Lagadinou, E.D.1
Sach, A.2
Callahan, K.3
Rossi, R.M.4
Neering, S.J.5
-
12
-
-
74949089659
-
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
-
Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, et al. (2010) Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest 120: 142-156.
-
(2010)
J Clin Invest
, vol.120
, pp. 142-156
-
-
Samudio, I.1
Harmancey, R.2
Fiegl, M.3
Kantarjian, H.4
Konopleva, M.5
-
13
-
-
84864081282
-
Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia
-
Schimmer AD, Skrtic M (2012) Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia. Expert Rev Hematol 5: 117-119.
-
(2012)
Expert Rev Hematol
, vol.5
, pp. 117-119
-
-
Schimmer, A.D.1
Skrtic, M.2
-
14
-
-
84901633005
-
Tigecycline compositions and methods of preparation
-
inventors; Wyeth LLC, assignee February 1 United States patent US. 7,879,828
-
Fawzi MB, Zhu T, Shah SM, inventors; Wyeth LLC, assignee (2011 February 1) Tigecycline compositions and methods of preparation. United States patent US. 7,879,828
-
(2011)
-
-
Fawzi, M.B.1
Zhu, T.2
Shah, S.M.3
-
15
-
-
24144445122
-
Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method
-
DOI 10.1128/AAC.49.9.3903-3909.2005
-
Bradford PA, Petersen PJ, Young M, Jones CH, Tischler M, et al. (2005) Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob Agents Chemother 49: 3903-3909. (Pubitemid 41233048)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.9
, pp. 3903-3909
-
-
Bradford, P.A.1
Petersen, P.J.2
Young, M.3
Jones, C.H.4
Tischler, M.5
O'Connell, J.6
-
16
-
-
29444448244
-
Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines
-
DOI 10.1093/jac/dki386
-
Hope R, Warner M, Mushtaq S, Ward ME, Parsons T, et al. (2005) Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. J Antimicrob Chemother 56: 1042-1046. (Pubitemid 43009817)
-
(2005)
Journal of Antimicrobial Chemotherapy
, vol.56
, Issue.6
, pp. 1042-1046
-
-
Hope, R.1
Warner, M.2
Mushtaq, S.3
Ward, M.E.4
Parsons, T.5
Livermore, D.M.6
-
17
-
-
7444219600
-
Quantitation of tigecycline, a novel glycyclcycline, by liquid chromatography
-
DOI 10.1016/j.jchromb.2004.09.011, PII S1570023204007457
-
Li C, Sutherland CA, Nightingale CH, Nicolau DP (2004) Quantitation of tigecycline, a novel glycylcycline [corrected] by liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 811: 225-229. (Pubitemid 39446769)
-
(2004)
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
, vol.811
, Issue.2
, pp. 225-229
-
-
Li, C.1
Sutherland, C.A.2
Nightingale, C.H.3
Nicolau, D.P.4
-
18
-
-
39449086721
-
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
-
DOI 10.1038/nprot.2007.521, PII NPROT.2007.521
-
Wiegand I, Hilpert K, Hancock RE (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3: 163-175. (Pubitemid 351266501)
-
(2008)
Nature Protocols
, vol.3
, Issue.2
, pp. 163-175
-
-
Wiegand, I.1
Hilpert, K.2
Hancock, R.E.W.3
-
19
-
-
0024599410
-
Expression of a retinoic acid receptor gene in myeloid leukemia cells
-
Wang C, Curtis JE, Minden MD, McCulloch EA (1989) Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia 3: 264-269. (Pubitemid 19092758)
-
(1989)
Leukemia
, vol.3
, Issue.4
, pp. 264-269
-
-
Wang, C.1
Curtis, J.E.2
Minden, M.D.3
McCulloch, E.A.4
-
20
-
-
27144477007
-
Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells
-
DOI 10.1038/sj.leu.2403917, PII 2403917
-
Warner JK, Wang JC, Takenaka K, Doulatov S, McKenzie JL, et al. (2005) Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells. Leukemia 19: 1794-1805. (Pubitemid 41486158)
-
(2005)
Leukemia
, vol.19
, Issue.10
, pp. 1794-1805
-
-
Warner, J.K.1
Wang, J.C.Y.2
Takenaka, K.3
Doulatov, S.4
McKenzie, J.L.5
Harrington, L.6
Dick, J.E.7
-
21
-
-
33644539489
-
Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors
-
Schimmer AD, Thomas MP, Hurren R, Gronda M, Pellecchia M, et al. (2006) Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors. Cancer Res 66: 2367-2375.
-
(2006)
Cancer Res
, vol.66
, pp. 2367-2375
-
-
Schimmer, A.D.1
Thomas, M.P.2
Hurren, R.3
Gronda, M.4
Pellecchia, M.5
-
22
-
-
34347236921
-
Organelle isolation: Functional mitochondria from mouse liver, muscle and cultured fibroblasts
-
Frezza C, Cipolat S, Scorrano L (2007) Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nature Protocols 2: 287.
-
(2007)
Nature Protocols
, vol.2
, pp. 287
-
-
Frezza, C.1
Cipolat, S.2
Scorrano, L.3
-
23
-
-
84855858726
-
Ascorbic acid: An old player with a broad impact on body physiology including oxidative stress suppression and immunomodulation: A review
-
Pohanka M, Pejchal J, Snopkova S, Havlickova K, Karasova JZ, et al. (2012) Ascorbic acid: an old player with a broad impact on body physiology including oxidative stress suppression and immunomodulation: a review. Mini Rev Med Chem 12: 35-43.
-
(2012)
Mini Rev Med Chem
, vol.12
, pp. 35-43
-
-
Pohanka, M.1
Pejchal, J.2
Snopkova, S.3
Havlickova, K.4
Karasova, J.Z.5
-
24
-
-
79955643881
-
Stable parenteral formulations of tigecycline
-
inventors; Ranbaxy Laboratories Ltd., assignee November 5 United States patent application US. 12/434,499. Publication number US 2009/02756660 A1
-
Chauhan B, Arora VK, Srivastava J, inventors; Ranbaxy Laboratories Ltd., assignee (2009 November 5) Stable parenteral formulations of tigecycline. United States patent application US. 12/434,499. Publication number US 2009/02756660 A1
-
(2009)
-
-
Chauhan, B.1
Arora, V.K.2
Srivastava, J.3
-
25
-
-
24144487712
-
Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent Oxyrase on in vitro activities of tigecycline against recent clinical isolates
-
DOI 10.1128/AAC.49.9.3910-3918.2005
-
Petersen PJ, Bradford PA (2005) Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent oxyrase on in vitro activities of tigecycline against recent clinical isolates. Antimicrob Agents Chemother 49: 3910-3918. (Pubitemid 41233049)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.9
, pp. 3910-3918
-
-
Petersen, P.J.1
Bradford, P.A.2
|